Teva Pharmaceutical Industries Ltd (TEVJF) Net Equity Issued and Repurchased (2015 - 2016)
Teva Pharmaceutical Industries' (TEVJF) quarterly Net Equity Issued and Repurchased came in at $329.0 million in Q1 2016, down 90.0% on a QoQ basis from $3.3 billion in Q4 2015.
Teva Pharmaceutical Industries Ltd (TEVJF) Net Equity Issued and Repurchased (2015 - 2016) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $329.0 million in Q1 2016.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $329.0 million in Q1 2016, while the trailing twelve-month figure through Dec 2016 was $329.0 million (down 90.0% YoY) and the FY2016 annual result came in at $329.0 million, down 90.0% from the prior year.
- Net Equity Issued and Repurchased eased to $329.0 million in Q1 2016, from $3.3 billion in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.3 billion in Q4 2015 to a low of $329.0 million in Q1 2016.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 329.00 Mn |
| Mar 31, 2016 | 329.00 Mn |
| Dec 31, 2015 | 3.29 Bn |
| Dec 31, 2015 | 3.29 Bn |